Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prognostic factors for long-term survival after glioblastoma.

Literature DB >> 21339920

Prognostic factors for long-term survival after glioblastoma.

Abstract

Long-term survivors of glioblastoma (GB) are rare. Several variables besides tumor size and location determine a patient's survival chances: age at diagnosis, where younger patients often receive more aggressive treatment that is multimodal; functional status, which has a significant negative correlation with age; and histologic and genetic markers.

Entities: Chemical

Year: 2008 PMID： 21339920 PMCID： PMC3037140 DOI： 10.7812/TPP/08-027

Source DB: PubMed Journal: Perm J ISSN： 1552-5767

31 in total

1. Proliferation index is related to patient age in glioblastoma.

Authors: P E McKeever; L Junck; M S Strawderman; M Blaivas; A Tkaczyk; M A Cates; M Yan; L Li
Journal: Neurology Date: 2001-05-08 Impact factor: 9.910

2. MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors: Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal: N Engl J Med Date: 2005-03-10 Impact factor: 91.245

3. Long-time survival of a patient with glioblastoma and Turcot's syndrome. Case report.

Authors: H P Rutz; N de Tribolet; J M Calmes; G Chapuis
Journal: J Neurosurg Date: 1991-05 Impact factor: 5.115

4. Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.

Authors: Nicholas F Marko; Steven A Toms; Gene H Barnett; Robert Weil
Journal: Genomics Date: 2008-03-17 Impact factor: 5.736

5. Statistical analysis of factors affecting survival after glioblastoma multiforme.

Authors: K Takeuchi; K Hoshino
Journal: Acta Neurochir (Wien) Date: 1977 Impact factor: 2.216

6. Coincidence vs cause: cure in three glioblastoma patients treated with brachytherapy.

Authors: Amir R Dehdashti; Sunjay Sharma; Normand Laperriere; Mark Bernstein
Journal: Can J Neurol Sci Date: 2007-08 Impact factor: 2.104

7. Ten-year survival among patients with supratentorial astrocytomas grade III and IV.

Authors: L G Salford; A Brun; S Nirfalk
Journal: J Neurosurg Date: 1988-10 Impact factor: 5.115

8. Long-term survival in patients with glioblastoma multiforme.

Authors: K L Chandler; M D Prados; M Malec; C B Wilson
Journal: Neurosurgery Date: 1993-05 Impact factor: 4.654

9. Prognostic significance of annexin VII expression in glioblastomas multiforme in humans.

Authors: Kuo-Sheng Hung; Shen-Long Howng
Journal: J Neurosurg Date: 2003-11 Impact factor: 5.115

10. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients.

Authors: G Minniti; V De Sanctis; R Muni; F Filippone; A Bozzao; M Valeriani; M F Osti; U De Paula; G Lanzetta; V Tombolini; R Maurizi Enrici
Journal: J Neurooncol Date: 2008-02-05 Impact factor: 4.130

47 in total

1. Prognostic Significance of Anatomic Origin and Evaluation of Survival Statistics of Astrocytoma Patients-a Tertiary Experience.

Authors: Ravindra Pramod Deshpande; Chandrasekhar Y B V K; Manas Panigrahi; Phanithi Prakash Babu
Journal: Indian J Surg Oncol Date: 2018-10-30

2. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.

Authors: Jinsen Zhang; Xing Xiao; Xin Zhang; Wei Hua
Journal: J Mol Neurosci Date: 2020-01-31 Impact factor: 3.444

Review 3. Fatigue among patients with brain tumors.

Authors: Arash Asher; Jack B Fu; Charlotte Bailey; Jennifer K Hughes
Journal: CNS Oncol Date: 2016-03-17

4. Characteristics and prognostic factors of age-stratified high-grade intracranial glioma patients: A population-based analysis.

Authors: Yun Sun; Zhi-Yong Xiong; Peng-Fei Yan; Liang-Lei Jiang; Chuan-Sheng Nie; Xuan Wang
Journal: Bosn J Basic Med Sci Date: 2019-11-08 Impact factor: 3.363

5. Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence.

Authors: Peter Liao; Quinn T Ostrom; Lindsay Stetson; Jill S Barnholtz-Sloan
Journal: Neuro Oncol Date: 2018-06-18 Impact factor: 12.300

6. An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.

Authors: Meng Zhou; Zhaoyue Zhang; Hengqiang Zhao; Siqi Bao; Liang Cheng; Jie Sun
Journal: Mol Neurobiol Date: 2017-05-19 Impact factor: 5.590

7. Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.

Authors: José L McFaline-Figueroa; Christian J Braun; Monica Stanciu; Zachary D Nagel; Patrizia Mazzucato; Dewakar Sangaraju; Edvinas Cerniauskas; Kelly Barford; Amanda Vargas; Yimin Chen; Natalia Tretyakova; Jacqueline A Lees; Michael T Hemann; Forest M White; Leona D Samson
Journal: Cancer Res Date: 2015-05-29 Impact factor: 12.701

Review 8. Glioblastoma: Overview of Disease and Treatment.

Authors: Mary Elizabeth Davis
Journal: Clin J Oncol Nurs Date: 2016-10-01 Impact factor: 1.027

9. Investigation of Inter- and Intratumoral Heterogeneity of Glioblastoma Using TOF-SIMS.

Authors: Samvel K Gularyan; Alexander A Gulin; Ksenia S Anufrieva; Victoria O Shender; Michail I Shakhparonov; Soniya Bastola; Nadezhda V Antipova; Tatiana F Kovalenko; Yury P Rubtsov; Yaroslav A Latyshev; Alexander A Potapov; Marat S Pavlyukov
Journal: Mol Cell Proteomics Date: 2020-04-06 Impact factor: 5.911

Review 10. The blood-tumour barrier in cancer biology and therapy.

Authors: Patricia S Steeg
Journal: Nat Rev Clin Oncol Date: 2021-07-12 Impact factor: 66.675